Department of Biomedical Sciences, University of Cagliari, 09042 Monserrato, Italy.
Bariatric Surgery Department, ARNAS Brotzu, 09121 Cagliari, Italy.
Nutrients. 2021 Dec 1;13(12):4340. doi: 10.3390/nu13124340.
Bariatric surger (BS) is characterized by lipid metabolic changes as a response to the massive release of non-esterified fatty acids (NEFA) from adipose depots. The study aimed at evaluating changes in polyunsaturated fatty acids (PUFA) metabolism and biosynthesis of the lipid mediators -acylethanolamines (NAE), as indices of nuclear peroxisome proliferator-activated receptor (PPAR)-α activation. The observational study was performed on 35 subjects (27 female, 8 male) with obesity, undergoing bariatric surgery. We assessed plasma FA and NAE profiles by LC-MS/MS, clinical parameters and anthropometric measures before and 1 and 6 months after bariatric surgery. One month after bariatric surgery, as body weight and clinical parameters improved significantly, we found higher plasma levels of -oleoylethanolamine, arachidonic and a 22:6-n3/20:5-n3 ratio as evidence of PPAR-α activation. These changes corresponded to higher circulating levels of NEFA and a steep reduction of the fat mass. After 6 months 22:6-n3/20:5-n3 remained elevated and fat mass was further reduced. Our data suggest that the massive release of NEFA from adipose tissue at 1-Post, possibly by inducing PPAR-α, may enhance FA metabolism contributing to fat depot reduction and improved metabolic parameters in the early stage. However, PUFA metabolic changes favor n6 PUFA biosynthesis, requiring a nutritional strategy aimed at reducing the n6/n3 PUFA ratio.
减重手术(BS)的特点是脂肪代谢发生变化,这是对脂肪组织中非酯化脂肪酸(NEFA)大量释放的反应。本研究旨在评估多不饱和脂肪酸(PUFA)代谢和脂质介质酰基乙醇胺(NAE)的生物合成变化,作为核过氧化物酶体增殖物激活受体(PPAR)-α激活的指标。该观察性研究共纳入 35 名肥胖患者(27 名女性,8 名男性),他们接受了减重手术。我们通过 LC-MS/MS 评估了血浆 FA 和 NAE 谱,在减重手术前和术后 1 个月和 6 个月评估了临床参数和人体测量指标。减重手术后 1 个月,随着体重和临床参数的显著改善,我们发现 - 油酰乙醇胺、花生四烯酸和 22:6-n3/20:5-n3 比值的血浆水平升高,这是 PPAR-α 激活的证据。这些变化与循环 NEFA 水平升高和脂肪量急剧减少相对应。6 个月后,22:6-n3/20:5-n3 仍然升高,脂肪量进一步减少。我们的数据表明,术后 1 个月脂肪组织中大量的 NEFA 释放,可能通过诱导 PPAR-α,增强 FA 代谢,有助于减少脂肪储存和改善早期代谢参数。然而,PUFA 代谢变化有利于 n6 PUFA 的生物合成,需要采用旨在降低 n6/n3 PUFA 比值的营养策略。